Tag: narrow therapeutic index

Narrow Therapeutic Index Drugs: Why Bioequivalence Rules Are Tighter for These Medications

Narrow therapeutic index drugs require stricter bioequivalence standards because small differences in dosage can cause serious harm. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin, levothyroxine, and digoxin to ensure patient safety.